Thomas P. O'Neil, Chief Financial Officer at Satsuma Pharmaceuticals, Inc. (STSA), sold 750 shares at $22.19 ($17K) on 2020-09-01, disclosed to the SEC on 2020-09-03.
Scheduled sale ($17k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| STSA | SELL | 2020-06-24 | $149K | — | Filing → |
| STSA | SELL | 2020-06-02 | $25K | — | Filing → |
| STSA | SELL | 2020-05-21 | $50K | — | Filing → |